Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260465E, 2605011, 560 57, 560101, 562468, 562491, 564272, 564304, 564308, 568326, 514555, 514647, A61K 31135, A61K 31205, C07C 8764

Patent

active

045566763

ABSTRACT:
Novel trans-isomeric derivatives of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine are useful as antidepressant agents. These novel compounds act to block the synaptosomal uptake of norepinephrine and serotonin (5-hydroxy-tryptamine), thereby alleviating abnormalities at central receptor sites. The preferred embodiment is the enantiomer trans-(1R)-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalen amine and its pharmaceutically acceptable acid addition salts.

REFERENCES:
patent: 3704323 (1972-11-01), Krapcho
patent: 4045488 (1977-08-01), Sarges
Burger, "Medicinal Chemistry", 3rd Ed., Part II, pp. 1470, 1473-1475, 1478-1479 and 1489-1493, (1970).
Koe, "The Jour. Pharmacology and Experimental Therapeutics", vol. 199, No. 3, pp. 649-661, (1976).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro- does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro- will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1394987

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.